Avinash Bajaj

About

Avinash Bajaj is a trained Chemical Biologist with his PhD training from Indian Institute of Science, Bangalore, India. He then moved to University of Massachusetts at Amherst. He worked with Prof. Vincent Rotello,in bionanotechnology. He returned to India in August 2013 and joined as Assistant Professor Regional Centre for Biotechnology, newly established institute by Department of Biotechnology, Govt. of India. His lab in involved in unraveling the chemical-biology approaches to address the problems in Cancer and other diseases using inter-disciplinary approaches of Chemistry, Nanotechnology, Molecular Biology and Pharmacology.

Employment

• Regional Centre for Biotechnology Associate Professor
  2016 - Present
• Regional Centre for Biotechnology Assistant Professor
  2010 - Present

Education

• University of Massachusetts Amherst Research Associate
  2008 - 2010
• Indian Institute of Science Graduate Student, PhD
  2003 - 2008

Projects & Funding

Projects & funding information is unavailable.

Publications (64)

• Microparticle uptake reduces efferocytic capacity of macrophages
  Biomaterials Science 2026 DOI: 10.1039/D5BM01447F
  +Save
• Aspirin‐Conjugated Cholic Acid Derivative Combats Polymicrobial Infections and Inflammation
  ChemMedChem 2025 DOI: 10.1002/cmdc.202500174
  +Save
• Docetaxel-conjugated bile acid-derived nanomicelles can inhibit tumour progression with reduced toxicity
  Nanoscale Advances 2025 DOI: 10.1039/D4NA00715H
  +Save
• Engineered Nanomicelles Delivering the Combination of Steroids and Antioxidants Can Mitigate Local and Systemic Inflammation, Including Sepsis
  ACS Applied Materials & Interfaces 2025 DOI: 10.1021/acsami.4c14159
  +Save
• Recent Advances in the Development of Antifungal Agents: Beyond Azoles, Polyenes, and Echinocandins
  ACS Infectious Diseases 2025 DOI: 10.1021/acsinfecdis.4c00828
  +Save
• Enzymatically Regulated pH-Responsive Hydrogel with Intrinsic Electromechanical Cue toward Myoblast Differentiation
  Chemistry of Materials 2025 DOI: 10.1021/acs.chemmater.5c01064
  +Save
• Localized Hydrogel-Mediated Docetaxel-Carboplatin Combination Chemotherapy Targets Ganglioside Metabolism to Mitigate Tumor Progression
  ACS Pharmacology & Translational Science 2025 DOI: 10.1021/acsptsci.5c00203
  +Save
• Ponatinib Averts αCD40 Antibody Mediated Toxicity by Lowering MAPK38 Expression and Shows Proimmunogenic Effects in a Murine Tumor Model
  ACS Pharmacology & Translational Science 2025 DOI: 10.1021/acsptsci.5c00227
  +Save
• Unveiling the Role of Mechanistic Target of Rapamycin Kinase (MTOR) Signaling in Cancer Progression and the Emergence of MTOR Inhibitors as Therapeutic Strategies
  ACS Pharmacology & Translational Science 2024 DOI: 10.1021/acsptsci.4c00530
  +Save
• Cholic Acid-Derived Gemini Amphiphile Can Eradicate Interkingdom Polymicrobial Biofilms and Wound Infections
  ACS Infectious Diseases 2024 DOI: 10.1021/acsinfecdis.3c00369
  +Save